Orchid Pharma Limited — Credit Ratings, 02-04-2026: Credit Rating- Revision

CARE Ratings has downgraded Orchid Pharma's Long-Term Bank Facilities (₹207.50 Cr) to CARE BBB+ (Stable Outlook) from CARE A-. For the ₹75.00 Cr Long Term/Short Term facilities, the Long-Term rating was downgraded to CARE BBB+ (Stable), while the Short-Term rating was reaffirmed at CARE A2. Short Term Bank Facilities (₹84.00 Cr) were also reaffirmed at CARE A2. These actions reflect a review of the company's operational & financial performance.